Our CEO @NicoleWagnerPhD will join the Unstoppable Women event at the @IntrepidMuseum in NYC on 11/19.
We’re proud to be part of a conversation on women-led innovation as we continue to advance our artificial retina.
https://t.co/R7aBghif0a
#WomenInBiotech
By taking risks and challenging what's possible, Nicole Wagner is propelling her company, LambdaVision, to new heights! 🚀
LambdaVision-1, an experiment exploring artificial retina manufacturing, is one of several experiments delivered to the International Space Station as part of NASA’s SpaceX 35th commercial resupply services mission.
Next stop: the Intrepid Museum where LambdaVision CEO Nicole Wagner, Ph.D., will take the stage at our Unstoppable Women fundraising event on November 19!
Be part of the conversation! Tickets are on sale now. https://t.co/lhiIlm78lK
A great evening celebrating the future of space innovation & 5 years of @aurelia_labs Gala, hosted by @ariel_ekblaw!
Proud to be part of a growing community advancing the commercial space economy & translating space-based research into benefits for life on Earth.
#SpaceBiotech
LambdaVision is featured in @PharmExec's latest article on microgravity's potential for biotech R&D & manufacturing.
Thanks to Sophia Goeppinger & Raphael Roettgen of E2MC for highlighting our 10 ISS missions & artificial retina research!
https://t.co/0CmRZ3V3GB
#SpaceBiotech
We're heading to @UFHealth!
Kristin will join a panel discussion, while Gauri presents a research poster highlighting LambdaVision's work.
Looking forward to connecting w/ innovators advancing biotechnology & space-based research!
Learn more: https://t.co/rgneRCDoL4
Thank you to @FightBlindness for hosting Vision Connection in Florida!
LambdaVision’s Kristin Kopperud, Ph.D., attended & spoke about our artificial retina & the role of space-enabled manufacturing in advancing our technology.
#VisionResearch
From space-based research to commercial opportunity.
CEO @NicoleWagnerPhD attended #UpLink2026 in NYC, connecting w/ leaders advancing investment, partnerships & commercial growth across the space economy.
#SpaceBiotech
Our CEO @NicoleWagnerPhD joins the Frontier Technology panel at NGEN SpaceTech in NYC today.
At LambdaVision, frontier tech serves a clear biotech mission: advancing an artificial retina.
Our work builds on 10 @ISS_CASIS missions and one mission beyond the ISS.
#SpaceTech
Ahead of #NationalSTEMDay, we're celebrating the power of collaboration across science, engineering & technology.
At LambdaVision, this work is advancing our artificial retina, from labs on Earth to 10 missions aboard the ISS & one beyond!
#STEAM
Today, LambdaVision’s Kristin Kopperud is speaking at the @FightBlindness Vision Connection event in Florida!
We’re excited to share our work developing a protein-based artificial retina w/ the vision loss community.
#VisionResearch
A busy October for #TeamLambdaVision: Türkiye, Switzerland, Japan, Florida and California.
Across vision research, microgravity, microfluidics and biomanufacturing, one mission connects it all: advancing our artificial retina toward patients.
#TeamLambdaVision
Today at @SelectBio Space Summit West, LambdaVision’s Kristin Kopperud presents:
“In-Space Production of Protein-Based Artificial Retinas”
She’ll share lessons from 10 ISS missions & our work toward scalable microgravity biomanufacturing.
Full agenda: https://t.co/50SGsutz3b
We’re excited to welcome David Dai to LambdaVision as Senior Research Scientist!
David joins our growing team to support our research & development efforts as we continue advancing our artificial retina.
Welcome, David!
Welcome to LambdaVision, Lauren Kriss, our new Director of Operations.
We’re excited to have Lauren join #TeamLambdaVision as we continue advancing our artificial retina & growing our Earth and space-based research & manufacturing programs.
This week, LambdaVision will be at @SelectBio's Lab-on-a-Chip & Microfluidics World Congress.
Microfluidics has played an important role in the evolution of our flight hardware & scalability in microgravity.
Learn more: https://t.co/GxoHSNYUOI
#SpaceBiotech#VisionResearch
Great to be part of #FestivalOfBiologics in Basel!
CEO @NicoleWagnerPhD joined leaders from BioOrbit, Women in Space Biotech & MEDES to discuss how microgravity could advance protein production & the future of biomanufacturing.
Thank you to the organizers & fellow panelists!
Last week at IAC 2026 in Antalya, we had a highly fruitful discussion on the future of microgravity research and in-space manufacturing.
It was a pleasure to moderate this Special Session which brought together distinguished experts, Dr. Pınar Mesci of @Axiom_Space, Mary Murphy of @voyagertech_ , Mike Gold of @Redwire and Dr. Nicole Wagner of @LambdaVision.
From advanced materials, compound semiconductors and crystal growth to tissue engineering, cancer research, novel therapeutics and biomanufacturing, we discussed where microgravity can provide advantages that simply cannot be replicated in the same way on Earth and what still needs to be solved before these capabilities can be deployed at commercial scale.
Microgravity research is about much more than enabling humanity’s future in space. Over the coming decades, it has the potential to contribute meaningful solutions to some of the major health and climate related challenges facing our global community. And alongside that societal impact lies a major economic opportunity. If we can successfully translate scientific discoveries made in microgravity into scalable products, we can create significant financial value and entirely new industries at the intersection of space, medicine, biotechnology and advanced manufacturing.
Once again, many thanks to our distinguished panelists and everyone who joined us in Antalya for contributing to this important conversation.
Ad astra 🚀
ICYMI: Our Q3 newsletter is live!
From two October space missions to features in @ScienceMagazine & @Reuters, we're sharing our latest milestones as we advance our artificial retina toward clinical development.
Subscribe here: https://t.co/NUyG9b9LAw
#SpaceBasedResearch
Why study our artificial retina protein in space?
Microgravity reduces forces such as sedimentation & convection that can affect production on Earth.
Our latest orbital mission is helping us study the protein in orbit & advance future quality-control approaches.
#SpaceBiotech
We’re heading back to space!
Today, we launch aboard @SpaceX-35 to the @ISS_CASIS w/ longtime partner @space_tango.
This is our 10th ISS mission; we’re continuing to advance the microgravity manufacturing processes behind our artificial retina.
https://t.co/dCxIrZtdZm
CEO @NicoleWagnerPhD is headed to @festofbiologics in Basel.
New for 2026: a focus on Space & Microgravity Environments.
Nicole will join a keynote panel exploring microgravity & the future of biomanufacturing.
https://t.co/SzV7Eoy47V